Dosage unit comprising a prostaglandin analog for treating constipation
DC
First Claim
1. A dosage unit comprising a prostaglandin (PG) analog represented by Formula (I) and/or its tautomers, and a pharmaceutically suitable excipient, wherein the dosage unit contains said PG analog in an amount of 24 μ
- g+/−
10%;
5 Assignments
Litigations
0 Petitions
Accused Products
Abstract
A dosage unit for treating constipation in a human patient is described. The dosage unit of the invention includes a halogenated prostaglandin analog and a pharmaceutically suitable excipient. The dosage unit relieves constipation without substantial side effects. In particular, the dosage unit includes a prostaglandin (PG) analog represented by Formula (I) and/or its tautomers, and a pharmaceutically suitable excipient, wherein the dosage unit contains the PG analog in an amount of 24 μg+/−10%:
20 Citations
13 Claims
- 1. A dosage unit comprising a prostaglandin (PG) analog represented by Formula (I) and/or its tautomers, and a pharmaceutically suitable excipient, wherein the dosage unit contains said PG analog in an amount of 24 μ
Specification
-
- Resources
-
Current AssigneeSucampo AG (Mallinckrodt plc)
-
Original AssigneeSucampo AG (Mallinckrodt plc)
-
InventorsUeno, Ryuji, Patchen, Myra L.
-
Primary Examiner(s)McCormick, Melenie
-
Assistant Examiner(s)HUANG, GIGI GEORGIANA
-
Application NumberUS13/330,942Publication NumberTime in Patent Office441 DaysField of Search514/302, 514/469US Class Current514/302CPC Class CodesA61K 31/557 Eicosanoids, e.g. leukotrie...A61P 1/00 Drugs for disorders of the ...A61P 1/10 LaxativesA61P 1/14 Prodigestives, e.g. acids, ...A61P 43/00 Drugs for specific purposes...C07C 53/23 containing ringsC07D 311/94 condensed with rings other ...
